UnitedHealth

UnitedHealth exceeded adjusted earnings expectations with $4.69 per share (expectation $4.12) and raised its full-year forecast to at least $20.50 per share. Revenue was $112.7 billion and net income rose to $4.11 billion versus $2.35 billion a year earlier. The stock rose intraday by over three percent and surpassed the 50-day line at $386.06; analysts see on average more than 21% upside and predominantly recommend buy. » More on deraktionaer.de

UnitedHealth beat earnings expectations in the third quarter with adjusted EPS of $4.69 and raised its 2026 annual forecast to at least $20.50. Revenue fell slightly, but profitability and operating margin improved thanks to lower medical costs, better cost management, and a favorable reserve development. Optum contributed with higher operating results, while membership — particularly in Medicare Advantage — declined, posing a risk to the sustainability of margins. » More on finanzen.net

UnitedHealth, under new management led by Stephen Hemsley, aims to cut operating expenses and the medical loss ratio and is pursuing a "shrink-to-grow" strategy that may depress revenue and member counts in the short term. The company remains under pressure from rising treatment volumes, probes into billing practices, a cyberattack and the death of CEO Brian Thompson. Analysts expect Q3 revenue declines but an adjusted EPS of about $4.14; steady Medicare star ratings are seen as a positive sign of business resilience. Investors will mainly watch progress on the turnaround and balance-sheet strengthening. » More on finanzen.net

UnitedHealth combines insurance and health services through UnitedHealthcare and Optum and benefits from demographic trends such as an aging population and the growth of Medicare Advantage. The group has raised its profit forecast and sees a strong autumn window for further growth. Core business areas are insurance premiums, patient care, pharmacy and drug services, and data and technology solutions. » More on finanzen.net

UnitedHealth will release results for the quarter ended Sept. 30, 2026 on Oct. 13, 2026. 25 analysts estimate EPS at an average of $4.12 versus $2.59 in the year-ago quarter. 20 analysts expect revenue of $111.31 billion, a decline of 1.63% from $113.16 billion a year earlier. For the current fiscal year, the average estimates are $19.95 earnings per share and $446.01 billion in revenue. » More on finanzen.net